JNJ three-lens brief
Evidence-based stock research on JNJ. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 15.5pp over 30 days. · Debt-to-equity of 67.7 — balance-sheet-heavy.
- Underperforming SPY by 15.5pp over 30 days.
- Debt-to-equity of 67.7 — balance-sheet-heavy.
JNJ closed at $225.40 (-0.79%) as of 2026-05-04. Market cap: $542.57B. P/E (trailing) 26.1. Concerns: underperforming SPY by 15.5pp over 30 days.; debt-to-equity of 67.7 — balance-sheet-heavy.. Last quarter: Revenue $24.06B, net income $5.24B, free cash flow $12.51B.
Why three lenses on JNJ, not one.
A single reasoning model has blind spots it doesn’t know about. We examine JNJacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/JNJ" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath JNJ brief"></iframe>